Evidence-based therapy according to the guideline for gastric ulcers is cost-effective in Japan

Journal of Physiology and Pharmacology

Volumn 62, Issue 6, 2011, Pages 627-635

  Taniyama, K ^a   Shimbo, T ^b   Iwase, H ^c   Tanaka, S ^d   Watanabe, N ^e   Uemura, N ^f  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^e National Hospital Organization Mie Chuo Medical Center   (Japan)

^f 1 7 1 Kohnodai   (Japan)

Author keywords

Cost effectiveness; Eradication; Gastric ulcer; Guideline; Helicobacter pylori; Histamine H 2; Non steroidal anti inflammatory drugs; Proton pump inhibitors; Receptor antagonists

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; FEMALE; GASTROSCOPY; HEALTH CARE COST; HELICOBACTER INFECTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; RECURRENT DISEASE; RETROSPECTIVE STUDY; STOMACH ULCER;

ADULT; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HELICOBACTER INFECTIONS; HUMANS; JAPAN; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; STOMACH ULCER;

EID: 84856938017     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Research group for assesment and adaptation of guideline for gastric ulcer. Evidence-based guideline for gastric ulcer treatment (in Japanese). Tokyo, Jiho K.K., 2003.
2. nd Ed. Tokyo, Jiho K.K., 2007.
3. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281: 1900-1905.
4. Uemura N, Okamoto S, Taniyama K, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
5. Fukuhara S, Suzukamo Y. Manual of SF-36v2 Japanese version (in Japanese). Kyoto, Institute for Health Outcomes & Process Evaluation Research, 2004.
6. Karczewska E, Wojtas I, Sito E, et al. Assessment of coexistence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract. J Physiol Pharmacol 2009; 60(Suppl 6): 33-39.
7. Loster BW, Czesnikiewicz-Guzik M, Bielanski W, et al. Prevalence and characterization of Helicobacter pylori (H. pylori) infection and colonization in dentists. J Physiol Pharmacol 2009; 60(Suppl 8): 13-18.
8. Sugiyama T. Gastric ulcer. In: Helicobacter pylori and the Eradication Therapy (in Japanese). Terano A, Takahashi S, (eds.) Tokyo, Nankodo, 2003, pp. 31-36.
9. Nomura A, Stemmermann GN, Chyou PH, Perez-perez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994; 120: 977-981.
10. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22.
11. Sung JJ, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-142.
12. Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994; 29: 1070-1075.